Related Experiment Video
Updated: Jan 25, 2026
07:02
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
13.1K
Kaposi sarcoma development following microscopic polyangiitis treatment
Mehmet Biricik1, Merve Eren1, Feyzi Bostan1
1Department of Internal Medicine, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Summary
Kaposi sarcoma (KS), a rare cancer, typically affects immunosuppressed individuals. This case highlights KS development in a patient undergoing immunosuppressive therapy for systemic vasculitis, a rare occurrence.
Area of Science:
- Oncology
- Rheumatology
- Immunology
Background:
- Kaposi sarcoma (KS) is a rare cancer predominantly affecting immunocompromised individuals, often linked to syndromes or organ transplantation.
- While KS is rare in rheumatologic disease patients, some cases involve long-term corticosteroid and cyclophosphamide treatment.
- Systemic vasculitis is an autoimmune condition characterized by inflammation of blood vessels.
Observation:
- A patient with systemic vasculitis developed Kaposi sarcoma.
- The patient had undergone treatment with long-term corticosteroids and cyclophosphamide.
- This presentation is unusual, given the typical patient profile for KS.
Findings:
- The development of Kaposi sarcoma in this case is linked to immunosuppressive therapy for systemic vasculitis.
- This case adds to the limited literature on KS in patients with rheumatologic conditions.
- The findings underscore the importance of considering KS in immunosuppressed patients, even those with autoimmune diseases.
Implications:
- Clinicians should maintain a high index of suspicion for Kaposi sarcoma in patients with rheumatologic diseases receiving long-term immunosuppressive therapy.
- Further research is warranted to understand the specific risk factors and mechanisms of KS development in this patient population.
- Early diagnosis and management of KS can improve outcomes for affected individuals.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
6.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.3K
01:13Microscopic Anatomy of Skeletal Muscles
22.5K
Skeletal muscle cells, also called muscle fibers, are distinctly elongated, multi-nucleated, slender biological units. They are packed with specialized structures designed to facilitate their primary function, which is contraction.
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
22.5K
01:43Sustainable Development
14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
01:24Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
01:22Alzheimer's Disease: Treatment
850
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
850
01:27Open Angle Glaucoma: Treatment
973
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
973